Something's got to give: psychiatric disease on the rise and novel drug development on the decline
- 1 February 2013
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 18 (3-4), 202-206
- https://doi.org/10.1016/j.drudis.2012.08.003
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophreniaTrends in Pharmacological Sciences, 2011
- Linked open drug data for pharmaceutical research and developmentJournal of Cheminformatics, 2011
- Many are called, yet few are chosen. Are neuropsychiatric clinical trials letting us down?Drug Discovery Today, 2011
- Case–case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genesPsychiatric Genetics, 2011
- Developmental pathology, dopamine, stress and schizophreniaInternational Journal of Developmental Neuroscience, 2010
- Mental health literacy among young people in a small US town: recognition of disorders and hypothetical helping responsesEarly Intervention in Psychiatry, 2010
- Signaling pathways in schizophrenia: emerging targets and therapeutic strategiesTrends in Pharmacological Sciences, 2010
- Depression research: where are we now?Molecular Brain, 2010
- Lessons from 60 years of pharmaceutical innovationNature Reviews Drug Discovery, 2009
- Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic riskMolecular Psychiatry, 2008